Journal: eLife
Article Title: CDK-mediated phosphorylation of PNKP is required for end-processing of single-strand DNA gaps on Okazaki fragments and genome stability
doi: 10.7554/eLife.99217
Figure Lengend Snippet: ( A ) Scheme and protein expression levels of GFP-PNKP-expressing HCT116 cells after release from double thymidine block. After released, cells were collected at indicated time points, and used for western blotting. pT118 PNKP antibody was generated for this study. Cyclin A2 and E1 antibodies were used for cell cycle markers. GAPDH antibody was used as a loading control. ( B ) In vitro analysis of PNKP phosphorylation on T118 by CDK/Cyclin complex. Purified His-PNKP and each CDK/Cyclin complex were incubated with reaction mixture and detected with western blotting by pT118-PNKP, His, GST, and Cyclin A2 antibodies. ( C ) HCT116 cells were lysed at 5 and 3 days after transfection with GFP-PNKP and co-transfection with mCherry2-Cyclin A2, and 3XFLAG-CDK1 or CDK2, respectively, and applied for western blotting. pT118 PNKP level was analyzed by pT118 PNKP-specific antibody. PNKP expression was analyzed with PNKP or GFP antibodies. Cyclin A2 expression was analyzed with RFP antibody. KAP1 antibody was used as loading control. ( D ) Analysis of isolated proteins from nascent DNA using isolation of proteins on nascent DNA (iPOND) technique. Proteins bound to EdU-labeled DNA in GFP-PNKP-expressing HEK293 cells were isolated using click reaction with biotin-azide followed by streptavidin-pulldowns and detected by western blotting. 0.1% of lysate used in Streptavidin-pulldowns represented as 0.1% input. ( E ) Western blotting to show interactions of GFP-PNKP WT or T118A with nascent DNA using the iPOND technique. PCNA was used as a loading control. ( F ) Western blotting to show interaction of PNKP with nascent DNA in XRCC1-depleted cells using the iPOND technique. PCNA was used as a loading control. Figure 4—source data 1. Original membranes corresponding to . Regions surrounded with red dashed line represent cropped areas, respectively. Annotations represent employed antibodies, respectively. Figure 4—source data 2. Original membranes corresponding to . Figure 4—source data 3. Original membranes corresponding to . Regions surrounded with red dashed line represent cropped areas, respectively. Annotations represent employed antibodies, respectively. Figure 4—source data 4. Original membranes corresponding to . Figure 4—source data 5. Original membranes corresponding to . Regions surrounded with red dashed line represent cropped areas, respectively. Annotations represent employed antibodies, respectively. Figure 4—source data 6. Original membranes corresponding to . Figure 4—source data 7. Original membranes corresponding to . Regions surrounded with red dashed line represent cropped areas, respectively. Annotations represent employed antibodies, respectively. Figure 4—source data 8. Original membranes corresponding to . Figure 4—source data 9. Original membranes corresponding to . Regions surrounded with red dashed line represent cropped areas, respectively. Annotations represent employed antibodies, respectively. Figure 4—source data 10. Original membranes corresponding to . Figure 4—source data 11. Original membranes corresponding to . Regions surrounded with red dashed line represent cropped areas, respectively. Annotations represent employed antibodies, respectively. Figure 4—source data 12. Original membranes corresponding to .
Article Snippet: For primary antibody reactions, the following primary antibodies were used for 1–4 hr at room temperature: PNKP (rabbit, 1:1000, Novus, cat# NBP1-87257), PNKP (rabbit, 1:1000, Abcam, cat# ab181107), pT118-PNKP (rabbit, 1:1000, generated in this paper), pS114-PNKP (rabbit, 1:1000, generated in this paper), XRCC1 (mouse, 1:1000, Invitrogen, Thermo Fisher Scientific, cat# MA5-13412), XRCC4 (rabbit, 1:1000, generated in our laboratory; ), PCNA (rabbit, 1:500, Santa Cruz Biotechnology, cat# sc-7907), KAP1 (rabbit, 1:1000, abcam, cat# ab10483), pS824-KAP1 (rabbit, 1:1000, BETHYL, cat# A300-767A-2), Cyclin-A2 (mouse, 1:1000, Cell signaling, cat# BF683), Cyclin-E1 (rabbit, 1:1000, Sigma-Aldrich, cat# C4976), GFP (mouse, 1:3000, Nacali Tesque Inc, cat# GF200), ATM (mouse, 1:2000, Sigma-Aldrich, cat# A1106), DNA-PKcs (rabbit, 1:2000, abcam, cat# Y393), p53 (mouse, 1:5000, Santa Cruz Biotechnology, cat# sc-126), RPA2 (mouse, 1:3000, abcam, cat# ab2175), GAPDH (mouse, 1:10,000, EMD Millipore, cat# MAB374), FLAG-M2 (mouse, 1:1000, Sigma-Aldrich, cat# A8592), RFP (rabbit, 1:1000, MBL, PM005), and FEN1 (mouse, 1:500, Santa Cruz, sc-28355).
Techniques: Expressing, Blocking Assay, Western Blot, Generated, Control, In Vitro, Phospho-proteomics, Purification, Incubation, Transfection, Cotransfection, Isolation, Labeling